We aim to identify more therapeutic opportunities in epigenetic pathways and immunotherapy in combination with radiotherapy. With CBTN, we hope to test the targets in the patient samples at diagnosis and after radiotherapy (autopsy samples) to understand the potential of combinatory treatment with radio therapy.
Get the Latest
news, articles, and resources sent to your inbox.
